AB
OLMA icon

Amalgamated Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Amalgamated Bank’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,871
Closed -$47K – 2448
2025
Q4 		$47K Buy
1,871
+460
+33% +$8.19K ﹤0.01% 1852
2025
Q3 		$14K Hold
1,411
– – ﹤0.01% 2311
2025
Q2 		$6K Hold
1,411
– – ﹤0.01% 2677
2025
Q1 		$5K Buy
1,411
+505
+56% +$2.54K ﹤0.01% 2679
2024
Q4 		$5K Hold
906
– – ﹤0.01% 2745
2024
Q3 		$11K Hold
906
– – ﹤0.01% 2407
2024
Q2 		$10K Hold
906
– – ﹤0.01% 2454
2024
Q1 		$10K Sell
906
-1,437
-61% -$18.5K ﹤0.01% 2453
2023
Q4 		$33K Sell
2,343
-269
-10% -$3.62K ﹤0.01% 2422
2023
Q3 		$32K Hold
2,612
– – ﹤0.01% 2445
2023
Q2 		$24K Buy
+2,612
New +$15.8K ﹤0.01% 2655
2022
Q2 		– Sell
-3,542
Closed -$15K – 3151
2022
Q1 		$15K Buy
+3,542
New +$19.5K ﹤0.01% 2882

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Amalgamated Bank's OLMA Position: Q1 2026 in Review

Amalgamated Bank sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 1,871 shares — an estimated $47K sold.

Amalgamated Bank first reported a position in OLMA in Q1 2022 and held it in 12 quarters. The position peaked at $47K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Amalgamated Bank reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,871 Olema Pharmaceuticals shares in Q1 2026, an estimated $47K.
  • Amalgamated Bank first reported a position in Olema Pharmaceuticals in Q1 2022 and held it in 12 quarters.
  • Amalgamated Bank's Olema Pharmaceuticals position peaked at $47K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.